CIK 0000868278 · Non-accelerated filer<br>Smaller reporting company
ProPhase Labs, Inc.
Sign in to watch- Ticker
- PRPH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232577138
- Phone
- (215) 345-0919
- Business address
- 711 STEWART AVE, SUITE 200, GARDEN CITY, NEW YORK, NY, 11530
- Former names
- QUIGLEY CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO & CHAIRMAN sold 50,000 shares at $2.75 ($137,500)
- 4 Open-market buy Director bought 50,000 shares at $2.75 ($137,500)
- 4 Gift CEO & CHAIRMAN gave 54,150 shares (gift)
- 4 Grant or award Director acquired 7,878 shares (grant or award)
- 4 Grant or award Director acquired 4,727 shares (grant or award)
- 4 Grant or award Director acquired 6,068 shares (grant or award)
- 4 Grant or award Director acquired 3,641 shares (grant or award)
- 4 Open-market buy Director bought 100,000 shares at $1.75 ($175,000)
- 4 Open-market sale CEO & CHAIRMAN sold 100,000 shares at $1.75 ($175,000)
- 4 Grant or award Director acquired 2,782 shares (grant or award)
- 4 Grant or award Director acquired 5,564 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 5,740 shares (grant or award)
- 4 Open-market buy Director bought 2,870 shares at $1.96 ($5,625)
- 4 Grant or award Director acquired 4,727 shares (grant or award)
Page 3 of 11 · 215 filings